ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Virus Program Report On Scientific Activities

August 8, 1975

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

P01 Reviewers Asked To Look Closely At Number Of Projects

October 2, 1992

1st Cancer Patients Treated With Gene Therapy At NIH

February 1, 1991

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001